Sol-Gel Technologies (SLGL) has released an update.
Sol-Gel Technologies has been granted an additional 180 days by Nasdaq to meet their minimum bid price requirement, following a transfer of their listing to the Nasdaq Capital Market. The company plans to address the compliance issue, potentially through a reverse stock split, while continuing to develop its dermatology products and clinical trials. Investors will be watching closely as Sol-Gel works to stabilize its stock price and maintain its Nasdaq listing.
For further insights into SLGL stock, check out TipRanks’ Stock Analysis page.